PRISM MarketView

Capricor Therapeutics Advances Treatment for Duchenne Muscular Dystrophy

New York, June 12, 2024 - PRISM MarketView - Shares in biotechnology company Capricor Therapeutics (Nasdaq: CAPR), rose on Tuesday after the company announced that it had successfully completed a Type-B meeting with the FDA regarding a Biologics License Application (BLA)...

12 June 2024

GrowGeneration (GRWG) Germinates New B2B Portal for Hydroponic Retailers and Garden Centers, Nationwide

New York, June 11, 2024 - PRISM MarketView - Hydroponic and organic garden retailer, GrowGeneration Corp. (GRWG) has announced the launch of the HRG Marketplace, a new B2B portal developed by the Horticultural Rep Group (HRG), its wholesale division and a leading distrib...

11 June 2024

MicroCap Moves: Creative Realities (CREX) Joins Russell Microcap and Appoints VP of New Business Development

New York, June 11, 2024 - PRISM MarketView - PRISM AdTech and Media Index company and leader in digital signage solutions, Creative Realities (CREX) has announced the appointment of David Schultz, as Vice President of New Business Development. Schultz had previously work...

11 June 2024

BrainsWay Advances Deep Transcranial Magnetic Stimulation for Major Depressive Disorder

New York, June 11, 2024 - PRISM MarketView - Global medical technology company, BrainsWay Ltd. (Nasdaq: BWAY), has initiated a prospective, randomized, controlled, multicenter clinical trial evaluating an accelerated treatment protocol for the Company’s proprietary Deep ...

11 June 2024

Vanda Pharmaceuticals Soars on Unsolicited Takeover Bid

New York, June 7, 2024 - PRISM MarketView - Shares in Vanda Pharmaceuticals (Nasdaq: VNDA) soared on Thursday after the company confirmed that it had received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the company for $8....

7 June 2024

Aethlon Medical to Initiate Clinical Trial for Blood Purification Device

New York, June 6, 2024 - PRISM MarketView - Medical Therapeutics company, Aethlon Medical (Nasdaq: AEMD) is topping the PRISM MarketView Medical Devices Index during the day on Thursday. The company provided an update this week on its planned Phase 1 safety, feasibility ...

6 June 2024

Hot MedTech Company SpectralAI (MDAI) Reaches 50% Enrollment on Its Burn Study

New York, June 6, 2024 - PRISM MarketView - The AI wound care medical company, SpectralAI (MDAI) is also a PRISM NextGen Tech and AI Index company and has announced it’s reached 50% enrollment at burn centers for its ongoing US burn study. This study is designed to test ...

6 June 2024

Full Steam Ahead: Dous Technology (DUOT) and Canadian Pacific KC Forge 3-Year Pact

New York, June 6, 2024 - PRISM MarketView - PRISM NextGen Tech and AI Index company, Dous Technologies (DUOT) who utilizes AI technology within railway systems and railway operator Canadian Pacific KC (CP), are poised to embark on an ambitious journey as they seal a thre...

6 June 2024

Equillium Reports “Compelling” Positive Phase 2 Data in Alopecia Treatment Trial

New York, June 6, 2024 - PRISM MarketView - Equillium Inc. (Nasdaq: EQ) has announced positive topline data from its Phase 2, single dose, proof-of-concept study of EQ101 in adult patients with alopecia areata (AA), an autoimmune disease that causes hair loss. EQ101 is a...

6 June 2024

Surrozen Doses First Patient in Alcohol-Associated Hepatitis Study

New York, June 5, 2024 - PRISM MarketView - Surrozen, Inc. (Nasdaq: SRZN), has dosed the first patient in a Phase 1b clinical study of SZN-043 in patients with severe alcohol-associated hepatitis. The open-label, multi-center clinical trial will enroll approximately 30 p...

5 June 2024